Preceptis Medical Closes Series B Financing

Preceptis Medical, Inc., a Minneapolis-based manufacturer of the Hummingbird® TTS (Tympanostomy Tube System), which enables alternatives to general anesthesia for pediatric ear tube placement, closed its Series B financing.

The amount of the deal was not disclosed.

The round was led by Montesy Helen (HK) Limited.

The company intends to use the funds to expand its commercial infrastructure, complete its office study and develop future pipeline services and technologies.

Led by Steve Anderson, CEO, Preceptis Medical manufactures pediatric surgical technologies designed especially for the needs of children. Its first product, the Hummingbird TTS, enables alternatives to general anesthesia for children’s ear tube procedures and reduces healthcare costs by enabling the procedure to be performed out of the expensive operating room.



Join the discussion